Skip to content

PHARMABAK

Active Private limited company (pre-2019)founded 2015active for 11 yearsFerdinand Elbersstraat 5, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 0578.906.094

Timeline

21 events since 2015

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 38 days before the deadline
Resignation: DANIEL BAKAR (director)Director discharge: DANIEL BAKAR (director (not named in the articles)) · General meeting of 26-11-20256 points ▸
  • General meeting, 26-11-2025
  • Director resignation, DANIEL BAKAR (director (not named in the articles))
  • Director discharge, DANIEL BAKAR (director (not named in the articles))
  • Board meeting, 26-11-2025
  • Director resignation, DANIEL BAKAR (daily management delegate)
  • Power of attorney, KRISTOF HUYCK

Open the deed in the Belgian Official Gazette

2025
Weakest financial year net -€29,717 The net result drops to -€29,717, the lowest from 2015 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0578906094
Annual accounts 2024 filed PDFmicro format · on the deadline day
2024
Back to profit net €4,082 The net result is €4,082, after one loss-making year.
Annual accounts 2023 filed PDFmicro format · 30 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 4 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 30 days late
2021
Highest result from 2015 to 2025 net €90,472 ▲1,237% The operating result of €104,281 and the net result of €90,472 are both a record.
Annual accounts 2020 filed PDFmicro format · 30 days late
2020
Annual accounts 2019 filed PDFmicro format · 35 days late
2019
Annual accounts 2018 filed PDFmicro format · 21 days late
2018
Equity above €100,000 equity €125,378 ▲125% After 3 profitable years in a row, equity reaches €125,378.
Annual accounts 2017 filed PDFmicro format · 26 days before the deadline
2017
Annual accounts 2016 filed PDFmicro format · 29 days late
2016
Back to profit net €23,737 The net result is €23,737, after one loss-making year.
Liquidity more than 5 times current ratio 3.59 The current ratio rises from 0.65 to 3.59. Short-term debt falls from €132,233 to €2,586.
Annual accounts 2015 filed PDFfull format · 25 days late
2015
Incorporation PDFpublished on 28-01-2015
First establishment Ferdinand Elbersstraat 5, Molenbeek-Saint-Jean

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 26 January 2015, PHARMABAK was incorporated.1 Total assets went from €390,973 in 2018 to €357,515 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps